Men who have sex with men and persons who inject drugs report missed testing opportunities.
Prostate and lung cancer expected to emerge as the most common types by 2030.
Overall, 38.8% of women and 53.8% of men had never been tested in 2011 to 2015.
Trogarzo is given intravenously once every 14 days in combination with other antiretrovirals
CKD occurrence was seen in 3.4% of HIV patients receiving the combination of medications.
Antiretroviral therapies have prolonged the survival of HIV patients, but the drugs can have adverse effects on the kidneys.
HIV-infected men and women had lower incidences of colorectal and lung cancer compared with the general population.
While antiretroviral therapy has allowed HIV patients to undergo kidney transplantation, allograft rejection remains high in this group.
HIV test performed at 1.0% of visits made by young males; higher rates for blacks, Hispanics.
HIV retransplant recipients have increased risk of death and graft loss versus HIV re-KT patients
Fewer than half of patients with TFD-linked AKI had renal function recovery after drug withdrawal.
Study finds a link with combination therapy based on a protease inhibitor and non-nucleoside reverse transcriptase inhibitor.
Survey of minority men aged 18-25 showed that 57.2% indicated that they or their partner did not use birth control at their last sexual encounter.
Although ban was lifted on such surgeries in 2013, none have taken place, researchers say.
Chronic diseases such as end-stage renal disease (ESRD) have now surpassed opportunistic infections as the leading cause of death among HIV-infected patients.
Refuting common wisdom, research shows that HIV patients fared better than those with hepatitis C.
In the absence of co-infection with hepatitis C virus, their graft and patient survival rates are similar to those of HIV-negative patients.
Tenofovir drug can lead to moderate kidney damage in some patients.
Lower post-transplant HIV DNA levels associated with sirolimus use.
Mortality rate is high, especially among patients with HIV/AIDS.
HIV-1 was found in podocytes or tubular cells of renal allografts in recipients who did not have detectable plasma levels of the virus.
HIV is strongest predictor of erectile dysfunction for young and middle-aged men.
Evidence suggests that HIV-positive patients have the same favorable outcomes in terms of patient and allograft survival as non-HIV positive kidney transplant recipients.
HIV is no longer a contraindication to transplantation, contends Dorry Segev, MD, PhD.
If Congress reversed its ban on allowing people with HIV to be organ donors after their death, approximately 500 HIV-positive patients with kidney or liver failure each year could get transplants within months instead of years, according to researchers.
The trend could be a response to cases of transplant-related HIV transmission in November 2007.
Clinicians should consider the possibility that HIV patients have both renal and cardiac disease.
HIV infection has an additive effect on microalbuminuria risk in patients with type 2 diabetes.
Few studies have looked at this population, but these patients may have very high energy needs.
Protection may stem from a decrease in the number of HIV target cells following the procedure.
Renal and Urology News Articles
- Aggressive Therapy Warranted for Gleason 10 Prostate Cancer
- PET/CT May Improve Imaging of Recurrent Prostate Cancer
- Adding MRI Does Not Boost Prostate Cancer Upgrading Rate
- Both High and Low Uric Acid Levels Tied to Higher Mortality
- Trulicity Labeling Updated to Include Data on T2D Patients With CKD
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)